Inari Medical Inc (NARI)
Pretax margin
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) (ttm) | US$ in thousands | 4,246 | 2,612 | -12,291 | -24,250 | -26,185 | -19,696 | -13,126 | -111 | 10,685 | 15,989 | 25,228 | 17,344 |
| Revenue (ttm) | US$ in thousands | 493,364 | 469,933 | 439,579 | 413,142 | 382,874 | 346,212 | 335,938 | 306,140 | 276,785 | 257,782 | 209,685 | 171,036 |
| Pretax margin | 0.86% | 0.56% | -2.80% | -5.87% | -6.84% | -5.69% | -3.91% | -0.04% | 3.86% | 6.20% | 12.03% | 10.14% |
December 31, 2023 calculation
Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $4,246K ÷ $493,364K
= 0.86%
The pretax margin of Inari Medical Inc has shown some variability over the past eight quarters. In Q4 2023, the pretax margin improved to 0.86%, compared to 0.56% in Q3 2023. However, the company had negative pretax margins in Q2 2023 (-2.80%) and Q1 2023 (-5.87%). This indicates a period of financial difficulty for the company in the first half of 2023. Comparing to the same quarter last year, the pretax margin has shown improvement as in Q4 2022 it was -6.83%, indicating a positive trend in profitability. Overall, it is essential for Inari Medical Inc to continue monitoring and improving its pretax margins to ensure sustainable profitability and financial health.
Peer comparison
Dec 31, 2023